New York Oncology/Hematology — Albany, New York

New York Oncology/Hematology is a clinical research site located in Albany, New York, United States 12206.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New York Oncology/Hematology has participated in 1 clinical trials.

Therapeutic areas: HER-2 Gene Amplification.

Sponsors: Merrimack Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology/Hematology?

New York Oncology/Hematology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology/Hematology conducted?

New York Oncology/Hematology has 1 clinical trials on record. Their work covers HER-2 Gene Amplification.

Is New York Oncology/Hematology accredited by Crixeo Health?

New York Oncology/Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology/Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.